Kline Ronald M, Bazell Carol, Smith Erin, Schumacher Heidi, Rajkumar Rahul, Conway Patrick H
Centers for Medicare and Medicaid Services, Baltimore, MD
Centers for Medicare and Medicaid Services, Baltimore, MD.
J Oncol Pract. 2015 Mar;11(2):114-6. doi: 10.1200/JOP.2014.002337. Epub 2015 Feb 17.
Cancer is a medically complex and expensive disease with costs projected to rise further as new treatment options increase and the United States population ages. Studies showing significant regional variation in oncology quality and costs and model tests demonstrating cost savings without adverse outcomes suggest there are opportunities to create a system of oncology care in the US that delivers higher quality care at lower cost.
The Centers for Medicare and Medicaid Services (CMS) have designed an episode-based payment model centered around 6 month periods of chemotherapy treatment. Monthly per-patient care management payments will be made to practices to support practice transformation, including additional patient services and specific infrastructure enhancements. Quarterly reporting of quality metrics will drive continuous quality improvement and the adoption of best practices among participants. Practices achieving cost savings will also be eligible for performance-based payments. Savings are expected through improved care coordination and appropriately aligned payment incentives, resulting in decreased avoidable emergency department visits and hospitalizations and more efficient and evidence-based use of imaging, laboratory tests, and therapeutic agents, as well as improved end of life care.
New therapies and better supportive care have significantly improved cancer survival in recent decades. This has come at a high cost, with cancer therapy consuming $124 billion in 2010. CMS has designed an episode-based model of oncology care that incorporates elements from several successful model tests. By providing care management and performance based payments in conjunction with quality metrics and a rapid learning environment, it is hoped that this model will demonstrate how oncology care in the US can transform into a high value, high quality system.
癌症是一种医学上复杂且昂贵的疾病,随着新治疗方案的增加以及美国人口老龄化,预计成本还会进一步上升。研究表明肿瘤学质量和成本存在显著的地区差异,模型测试显示在不产生不良后果的情况下可节省成本,这表明在美国有机会创建一个以更低成本提供更高质量护理的肿瘤护理体系。
医疗保险和医疗补助服务中心(CMS)设计了一种基于疗程的支付模式,以6个月的化疗治疗期为中心。将向医疗机构支付每月每位患者的护理管理费用,以支持机构转型,包括额外的患者服务和特定的基础设施改善。质量指标的季度报告将推动持续质量改进,并促使参与者采用最佳实践。实现成本节约的医疗机构也有资格获得基于绩效的支付。预计通过改善护理协调和适当调整支付激励措施可实现节约,从而减少可避免的急诊就诊和住院次数,更高效且基于证据地使用影像学检查、实验室检查和治疗药物,以及改善临终护理。
近几十年来,新疗法和更好的支持性护理显著提高了癌症生存率。这付出了高昂的代价,2010年癌症治疗花费了1240亿美元。CMS设计了一种基于疗程的肿瘤护理模式,该模式纳入了多项成功模型测试的要素。通过结合质量指标和快速学习环境提供护理管理和基于绩效的支付,希望该模式能展示美国的肿瘤护理如何转变为一个高价值、高质量的体系。